HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Taylor, D R Articles by Jongste, J C D Search for Related Content PubMed PubMed Citation Articles by Taylor, D R Articles by Jongste, J C D

Exhaled nitric oxide measurements: clinical application and interpretation

¹ Department of Medical and Surgical Sciences, Dunedin School of Medicine, University of Otago, P O Box 913, Dunedin, New Zealand
² Department of Paediatric Respiratory Medicine, Erasmus MC - Sophia Children’s Hospital, University Medical Centre, P O Box 2060, 3000 CB Rotterdam, The Netherlands

Correspondence to:
Correspondence to:
Professor D R Taylor
Department of Medical and Surgical Sciences, Dunedin School of Medicine, University of Otago, P O Box 913, Dunedin, New Zealand; robin.taylor{at}stonebow.otago.ac.nz

The use of exhaled nitric oxide measurements (F_ENO) in clinical practice is now coming of age. There are a number of theoretical and practical factors which have brought this about. Firstly, F_ENO is a good surrogate marker for eosinophilic airway inflammation. High F_ENO levels may be used to distinguish eosinophilic from non-eosinophilic pathologies. This information complements conventional pulmonary function testing in the assessment of patients with non-specific respiratory symptoms. Secondly, eosinophilic airway inflammation is steroid responsive. There are now sufficient data to justify the claim that F_ENO measurements may be used successfully to identify and monitor steroid response as well as steroid requirements in the diagnosis and management of airways disease. F_ENO measurements are also helpful in identifying patients who do/do not require ongoing treatment with inhaled steroids. Thirdly, portable nitric oxide analysers are now available, making routine testing a practical possibility. However, a number of issues still need to be resolved, including the diagnostic role of F_ENO in preschool children and the use of reference values versus individual F_ENO profiles in managing patients with difficult or severe asthma.

Abbreviations: AHR, airway hyperresponsiveness; CF, cystic fibrosis; COPD, chronic obstructive pulmonary disease; F_ENO, exhaled nitric oxide; FEV₁, forced expiratory volume in 1 second; ICS, inhaled corticosteroids; NO, nitric oxide; PCD, primary ciliary dyskinesia

Keywords: exhaled nitric oxide; asthma; diagnosis; monitoring; treatment

This article has been cited by other articles:

				P. Latzin and U. Frey Environmental exposure in relation to exhaled nitric oxide in newborns: is it all about timing? Eur. Respir. J., August 1, 2008; 32(2): 252 - 254. [Full Text] [PDF]

				I. H. van Veen, A. ten Brinke, P. J. Sterk, J. K. Sont, S. A. Gauw, K. F. Rabe, and E. H. Bel Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Eur. Respir. J., August 1, 2008; 32(2): 344 - 349. [Abstract] [Full Text] [PDF]

				K. G. Lim and C. Mottram The Use of Fraction of Exhaled Nitric Oxide in Pulmonary Practice Chest, May 1, 2008; 133(5): 1232 - 1242. [Abstract] [Full Text] [PDF]

				K. Kostikas, A. I. Papaioannou, K. Tanou, A. Koutsokera, M. Papala, and K. I. Gourgoulianis Portable Exhaled Nitric Oxide as a Screening Tool for Asthma in Young Adults During Pollen Season Chest, April 1, 2008; 133(4): 906 - 913. [Abstract] [Full Text] [PDF]

				T. J. Calvert, L. G. Chicoine, Y. Liu, and L. D. Nelin Deficiency of mitogen-activated protein kinase phosphatase-1 results in iNOS-mediated hypotension in response to low-dose endotoxin Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1621 - H1629. [Abstract] [Full Text] [PDF]

				A. Michils, S. Baldassarre, and A. Van Muylem Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients Eur. Respir. J., March 1, 2008; 31(3): 539 - 546. [Abstract] [Full Text] [PDF]

				B. Balbi, P. Pignatti, M. Corradi, P. Baiardi, L. Bianchi, G. Brunetti, A. Radaeli, G. Moscato, A. Mutti, A. Spanevello, et al. Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults Eur. Respir. J., October 1, 2007; 30(4): 769 - 781. [Abstract] [Full Text] [PDF]

				H. Dressel, C. Gross, D. de la Motte, J. Sultz, R. A. Jorres, and D. Nowak Educational intervention decreases exhaled nitric oxide in farmers with occupational asthma Eur. Respir. J., September 1, 2007; 30(3): 545 - 548. [Abstract] [Full Text] [PDF]

				A.-C. Olin, B. Bake, and K. Toren Fraction of Exhaled Nitric Oxide at 50 mL/s: Reference Values for Adult Lifelong Never-Smokers Chest, June 1, 2007; 131(6): 1852 - 1856. [Abstract] [Full Text] [PDF]

				J. C. de Jongste To Wheeze or Not to Wheeze: Prospective FENO-typing in Early Infancy Am. J. Respir. Crit. Care Med., December 15, 2006; 174(12): 1281 - 1282. [Full Text] [PDF]